Ursprung des Netzwerks ersten Grades von Martijn Bax
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
AstraZeneca BV
1
| Subsidiary | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Martijn Bax
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
NewAmsterdam Pharma Holding BV
 NewAmsterdam Pharma Holding BV BiotechnologyHealth Technology Part of NewAmsterdam Pharma Co. NV, NewAmsterdam Pharma Holding BV is a Dutch company that engages in research and development of transformative therapies for cardio metabolic diseases. The company is based in Naarden, the Netherlands. The company was founded in 2019 by John Jacob Pieter Kastelein. Michael H. Davidson has been the CEO of the company since 2020. NewAmsterdam Pharma Holding was acquired by Frazier Lifesciences Acquisition Corp. on November 22, 2022 for $468.74 million. | Biotechnology | Corporate Officer/Principal | |
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Vrije Universiteit Amsterdam | College/University | Doctorate Degree |
Statistik
International
| Niederlande | 3 |
| Vereinigtes Königreich | 2 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Marc Ditmarsch | 4 |
- Börse
- Insiders
- Martijn Bax
- Unternehmensverbindungen
